These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1104051)

  • 1. Letter: Gentamicin nephrotoxicity in patients with renal allografts.
    Anderton JL; Raeburn JA
    Br Med J; 1975 Oct; 4(5989):165-6. PubMed ID: 1104051
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Evidence of gentamicin nephrotoxicity in patients with renal allografts.
    Wellwood JM; Tighe JR
    Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1090323
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of gentamicin nephrotoxicity in patients with renal allografts.
    Wellwood JM; Simpson PM; Tighe JR; Thompson AE
    Br Med J; 1975 Aug; 3(5978):278-81. PubMed ID: 1097045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Gentamicin nephrotoxicity in patients with renal allografts.
    Wellwood JM; Thompson AE; Tighe JR
    Br Med J; 1975 Nov; 4(5994):463. PubMed ID: 1104073
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Gentamicin and cephalothin nephrotoxicity.
    Wooller HO
    N Z Med J; 1975 Dec; 82(553):394-5. PubMed ID: 1062721
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients.
    Termeer A; Hoitsma AJ; Koene RA
    Transplantation; 1986 Aug; 42(2):220-1. PubMed ID: 3526659
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity?
    Takeda A; Morozumi K; Yoshida A; Uchida K; Tominaga Y; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1994 Apr; 26(2):925-8. PubMed ID: 8171705
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercholesterolemia and chronic rejection of renal allografts.
    Blum CB
    Transplantation; 2001 Aug; 72(4):751-3. PubMed ID: 11544447
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney.
    Fabre J; Fillastre JP; Morin JP; Rudhardt M
    Contrib Nephrol; 1978; 10():53-62. PubMed ID: 668380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?
    Balakumar P; Rohilla A; Thangathirupathi A
    Pharmacol Res; 2010 Sep; 62(3):179-86. PubMed ID: 20434560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible acute renal toxicity by toxic sinergic effect between gentamicin and cyclosporine.
    Morales JM; Andres A; Prieto C; Diaz Rolòn JA; Rodicio JL
    Clin Nephrol; 1988 May; 29(5):272. PubMed ID: 3293857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrotoxicity of gentamicin. Conditions for the use of this antibiotic in the elderly and in the patient with renal insufficiency].
    Jungers P; Ganeval D; Kleinknecht D
    Nouv Presse Med; 1977 Mar; 6(11):923-6. PubMed ID: 846852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identifying the specific causes of kidney allograft loss: A population-based study].
    Lohéac C; Aubert O; Loupy A; Legendre C
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S39-S50. PubMed ID: 29606262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity with gentamicin or tobramycin.
    Emmerson AM; Reeves DS; Rimmer DM; Wise R
    Lancet; 1980 Jan; 1(8159):96. PubMed ID: 6101443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observation on the nephrotoxicity of gentamicin].
    Ma JM; Chen WY; Hsu ZH
    Zhonghua Nei Ke Za Zhi; 1986 Apr; 25(4):194-6, 252. PubMed ID: 3743213
    [No Abstract]   [Full Text] [Related]  

  • 16. Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats.
    El-Kashef DH; El-Kenawi AE; Abdel Rahim M; Suddek GM; Salem HA
    Can J Physiol Pharmacol; 2016 Mar; 94(3):278-86. PubMed ID: 26641937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
    Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effect of naringenin against gentamicin-induced nephrotoxicity in rats.
    Fouad AA; Albuali WH; Zahran A; Gomaa W
    Environ Toxicol Pharmacol; 2014 Sep; 38(2):420-9. PubMed ID: 25128772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin nephrotoxicity--morphologic and pharmacologic features.
    Bennet WM; Gilbert DN; Houghton D; Porter GA
    West J Med; 1977 Jan; 126(1):65-8. PubMed ID: 831368
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
    Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
    Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.